Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Positive phase II results for dose-finding study of oral Rambazole

July 16, 2007

Health Canada approves phase I trials of WBI-1001 for psoriasis

July 13, 2007

Recent patents report novel therapeutic agents for dermatological disorders

July 12, 2007

AnGes updates phase II study of NF-kappaB decoy oligodeoxynucleotide

July 12, 2007

New clinical information on R-115866 and adalimumab in psoriasis

July 6, 2007

Recent Otsuka and Basilea patents claim novel therapeutic agents for dermatological disorders

July 6, 2007

Daivobet Scalp gel filed for scalp psoriasis in U.S. and E.U.

July 5, 2007

CYT003-QbG10 shows no treatment effect in atopic dermatitis

July 5, 2007

Clinical trials with natural products in psoriasis

July 5, 2007

Kythera completes enrollment for phase II trial of ATX-201

July 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...